Terms: = Pancreatic cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610
49 results:
1. Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis.
Torun BC; Glehen O; Kepenekian V; Sardi A; Arjona-Sanchez A; Yonemura Y; Barat S; Morris D; Spiliotis J; Coccolini F; Sommariva A; Bartos A; Raza S; Speteen KV; Akin L; Irez T; Canbay E;
Eur J Surg Oncol; 2023 Aug; 49(8):1489-1494. PubMed ID: 37085403
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of KRAS Mutations in Gastrointestinal Tract Adenocarcinomas Reveals Site-Specific Mutational Signatures.
Wang L; Saeedi BJ; Mahdi Z; Krasinskas A; Robinson B
Mod Pathol; 2023 Feb; 36(2):100014. PubMed ID: 36853786
[TBL] [Abstract] [Full Text] [Related]
3. Generation of the novel anti-FXYD5 monoclonal antibody and its application to the diagnosis of pancreatic and lung cancer.
Hotta T; Nariai Y; Kajitani N; Kadota K; Maruyama R; Tajima Y; Isobe T; Kamino H; Urano T
Biochimie; 2023 May; 208():160-169. PubMed ID: 36621663
[TBL] [Abstract] [Full Text] [Related]
4.
Shen H; Lundy J; Strickland AH; Harris M; Swan M; Desmond C; Jenkins BJ; Croagh D
Cells; 2022 Oct; 11(19):. PubMed ID: 36231137
[No Abstract] [Full Text] [Related]
5. Outcomes of double-layer continuous suture hepaticojejunostomy in pancreatoduodenectomy and total pancreatectomy.
Napoli N; Kauffmann EF; Caputo R; Ginesini M; Asta F; Gianfaldoni C; Amorese G; Vistoli F; Boggi U
HPB (Oxford); 2022 Oct; 24(10):1738-1747. PubMed ID: 35654670
[TBL] [Abstract] [Full Text] [Related]
6. The optimal duration of capecitabine plus temozolomide in patients with well-differentiated pancreatic NETs with or without maintenance therapy.
Gao H; Dong J; Zhang W; Xu H; Ye L; Li H; Wang W; Liu L; Yu X
J Neuroendocrinol; 2022 Jun; 34(6):e13112. PubMed ID: 35380016
[TBL] [Abstract] [Full Text] [Related]
7. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence.
Amintas S; Fernandez B; Chauvet A; Chiche L; Laurent C; Belleannée G; Marty M; Buscail E; Dabernat S
Sci Rep; 2022 Feb; 12(1):2976. PubMed ID: 35194118
[TBL] [Abstract] [Full Text] [Related]
8. Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H
BMC Cancer; 2021 Dec; 21(1):1319. PubMed ID: 34886831
[TBL] [Abstract] [Full Text] [Related]
9. KRAS mutation analysis by droplet digital PCR of duodenal juice from patients with MODY8 and other pancreatic diseases.
Choi MH; Tjora E; Forthun RB; Engjom T; Ræder H; Hovland R; Molven A
Pancreatology; 2021 Dec; 21(8):1460-1465. PubMed ID: 34580018
[TBL] [Abstract] [Full Text] [Related]
10. Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound.
Kataoka K; Ishikawa T; Ohno E; Mizutani Y; Iida T; Ishikawa E; Furukawa K; Nakamura M; Honda T; Ishigami M; Kawashima H; Hirooka Y; Fujishiro M
Pancreatology; 2021 Oct; 21(7):1364-1370. PubMed ID: 34281790
[TBL] [Abstract] [Full Text] [Related]
11. CCDC88A/GIV promotes HBV replication and progeny secretion via enhancing endosomal trafficking and blocking autophagic degradation.
Wang X; Wei Z; Lan T; He Y; Cheng B; Li R; Chen H; Li F; Liu G; Jiang B; Lin Y; Lu M; Meng Z
Autophagy; 2022 Feb; 18(2):357-374. PubMed ID: 34190023
[TBL] [Abstract] [Full Text] [Related]
12. Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer.
Lee HS; Kim E; Lee J; Park SJ; Hwang HK; Park CH; Jo SY; Kang CM; Hong SM; Kang H; Jo JH; Cho IR; Chung MJ; Park JY; Park SW; Song SY; Han JM; Kim S; Bang S
EBioMedicine; 2021 Mar; 65():103218. PubMed ID: 33639403
[TBL] [Abstract] [Full Text] [Related]
13. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in pancreatic Adenocarcinoma: A Meta-Analysis.
Luo X; Yu B; Jiang N; Du Q; Ye X; Li H; Wang WQ; Zhai Q
Cancer Control; 2020; 27(1):1073274820977135. PubMed ID: 33269614
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
Grant RC; Denroche R; Jang GH; Nowak KM; Zhang A; Borgida A; Holter S; Topham JT; Wilson J; Dodd A; Jang R; Prince R; Karasinska JM; Schaeffer DF; Wang Y; Zogopoulos G; Berry S; Simeone D; Renouf DJ; Notta F; O'Kane G; Knox J; Fischer S; Gallinger S
Gut; 2021 Oct; 70(10):1894-1903. PubMed ID: 32933947
[TBL] [Abstract] [Full Text] [Related]
15. Intraductal placement of a fully covered metal stent with a long string for distal malignant biliary obstruction without endoscopic sphincterotomy: Prospective multi-center feasibility study.
Inoue T; Suzuki Y; Okumura F; Naitoh I; Sano H; Ibusuki M; Kitano R; Kobayashi Y; Ito K; Yoneda M
Dig Endosc; 2020 Sep; 32(6):949-956. PubMed ID: 31898346
[TBL] [Abstract] [Full Text] [Related]
16. [Circulating tumor cells in pancreatic cancer : Results of morphological and molecular analyses and comparisons with the primary tumor].
Timme-Bronsert S; Bronsert P; Werner M; Kulemann B; Höppner J
Pathologe; 2018 Dec; 39(Suppl 2):311-314. PubMed ID: 30483865
[TBL] [Abstract] [Full Text] [Related]
17. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent pancreatic cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract] [Full Text] [Related]
18. KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study.
Nakano Y; Kitago M; Matsuda S; Nakamura Y; Fujita Y; Imai S; Shinoda M; Yagi H; Abe Y; Hibi T; Fujii-Nishimura Y; Takeuchi A; Endo Y; Itano O; Kitagawa Y
Br J Cancer; 2018 Mar; 118(5):662-669. PubMed ID: 29360815
[TBL] [Abstract] [Full Text] [Related]
19. FNA smears of pancreatic ductal adenocarcinoma are superior to formalin-fixed paraffin-embedded tissue as a source of DNA: Comparison of targeted KRAS amplification and genotyping in matched preresection and postresection samples.
Hartley CP; Mahajan AM; Selvaggi SM; Rehrauer WM
Cancer Cytopathol; 2017 Nov; 125(11):838-847. PubMed ID: 29024530
[TBL] [Abstract] [Full Text] [Related]
20. Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research.
Baechmann S; Ormanns S; Haas M; Kruger S; Remold A; Modest DP; Kirchner T; Jung A; Werner J; Heinemann V; Boeck S
BMC Cancer; 2017 May; 17(1):374. PubMed ID: 28549417
[TBL] [Abstract] [Full Text] [Related]
[Next]
